FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080728 [Registered on: 18/02/2025] Trial Registered Prospectively
Last Modified On: 06/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Evaluate the Effect of Panchavalkaladi TailaYoni Pichu Dharan in the Management of Acharana Yonivyapad  
Scientific Title of Study   Randomised Controlled Clinical Trial to Evaluate the Effect of Panchavalkaladi TailaYoni Pichu Dharan in the Management of Acharana Yonivyapad with Special Reference to Pruritus Vulvae 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSayali Bharatkumar Vengurlekar  
Designation  PG Scholar  
Affiliation  R.A.Podar Medical (Ayu) college,worli 
Address  Gynaec Department first floor Podar Hospital ,Worli Mumbai -400018

Mumbai
MAHARASHTRA
400018
India 
Phone  7769849489  
Fax    
Email  sayalivengurlekar98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrManoj Vitthal Gaikwad  
Designation  HOD PROFESSOR in Obstetrics and Gynaecology Department  
Affiliation  R.A.Podar Medical Ayu College Worli  
Address  Gynaec and Obstetrics Department first floor Podar Hospital Worli

Mumbai
MAHARASHTRA
400018
India 
Phone  9822752816  
Fax    
Email  drmanojvgaikwad@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrManoj Vitthal Gaikwad  
Designation  HOD PROFESSOR in Obstetrics and Gynaecology Department  
Affiliation  R.A.Podar Medical Ayu College Worli  
Address  Gynaec and Obstetrics Department first floor Podar Hospital Worli

Mumbai
MAHARASHTRA
400018
India 
Phone  9822752816  
Fax    
Email  drmanojvgaikwad@gmail.com  
 
Source of Monetary or Material Support  
OPD NO 8 M.A.Podar Hospital Worli Mumbai 400018 Maharashtra India  
 
Primary Sponsor  
Name  Dr Sayali Bharatkumar Vengurlekar  
Address  First floor Gynaec and Obstetrics Department Podar Hospital Worli Mumbai 400018 Maharashtra India  
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sayali Bharatkumar Vengurlekar   M.A.Podar Hospital Worli   Department of Gynaecology and Obstetrics first floor Podar Hospital Worli Mumbai 400018
Mumbai
MAHARASHTRA 
7769849489

sayalivengurlekar98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC R A.Podar medical College Worli   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N00-N99||Diseases of the genitourinary system. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-yoni picu, योनि पिचु (Procedure Reference: Charak chiktsa , Procedure details: Once a day for 7 days )
(1) Medicine Name: Nimb tail , Reference: Bhav Prakash , Route: Vaginal, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Duration: 7 Days
2Intervention ArmProcedure-yoni picu, योनि पिचु (Procedure Reference: Charak chiktsa , Procedure details: Once a day for 7 days )
(1) Medicine Name: Panchavalkayadi tail , Reference: Charak chiktsa , Route: Vaginal, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Female 
Details  1) Female having per vaginal itiching.

2) Age between 18-70 yrs married female patient.

3) Female who are willing to participate 
 
ExclusionCriteria 
Details  ) Pregnant women

2) Local gynaecological causes like ovarian cyst, prolapse, fibromyoma, polyps.

3) Neoplasm (Cervical or uterine malignancy)

4) patients with bleeding disorders

5) Those suffering from congenital anomalies of genital tract

6) Pelvic inflammatory diseases

7) Patients with sexually transmitted diseases

8) Abnormal uterine bleeding

9) Patients with severe hepatic or cardiac or renal disorders

10) Those having leukaemia or platelet deficiency disorders

11) Females in their puerperium period

12) Patient with severe anaemia

13) HIV HbsAg VDRL,HPV positive patients

14) Patients with DM,HTN 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Significantly reduction in Pruritus   8 days 
 
Secondary Outcome  
Outcome  TimePoints 
Significantly reduction in Pruritus by using Panchavalkayadi tail yoni pichu than Nimb tail yoni pichu   8 days 
 
Target Sample Size   Total Sample Size="76"
Sample Size from India="76" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Objective - To evaluate whether the Panchavalkaladi Taila Yoni Pichu Dharan in Acharana YoniVyapad (yoni kandu) with special reference to pruritus vulva
Group A - Panchavalkayadi tail 
Group B - Nimb tail 
Appropriate Sampling Technique: Simple randomised sampling method by computerised random technique will be done for 76 female patients of age group 18 to 70 years.

The subjects will be randomised in two study groups i.e., Group A and B. The time and date of recruitment shall also be recorded in the enrolment log

Follow up: 8 th day.

Assessment Criteria: The study will be strictly based on assessment of subjective parameter by the grading them.

The data obtained will be analyzed statistically.

Observation and Results: Observation and results will be drawn according to assessment criteria.

Discussion: The observed phenomena will be discussed.

Conclusion: Conclusion will be drawn strictly on basis of statistical analysis and will be unbiased

Summary: The research study will be summarized in brief.

Ethical Consideration: The study will be conducted in accordance with ethical guidelines and inform consent from participant.
 
Close